Avidity Biosciences Inc. (RNA) Social Stream
AVIDITY BIOSCIENCES INC (RNA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RNA.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
RNA's average price target has moved up $3.27 over the prior 21 months.
Over the past 42 weeks, RNA's average upside potential has been 150.2%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
RNA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
RNA's average broker recommendation rating improved by 0.08 over the prior 16 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RNA as an investment opportunity.
- In the context of all US stocks, AVIDITY BIOSCIENCES INC's variance in analysts' estimates is lower than -609.63% of them.
- AVIDITY BIOSCIENCES INC's number of analysts covering the stock is higher than 274.33% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, AVIDITY BIOSCIENCES INC's average analyst price target is greater than 1102.66% of them.
- In terms of how AVIDITY BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 479.22% of that group.
In the Pharmaceutical Products industry, GBIO, RPTX, and GLS are the three stocks most similar to AVIDITY BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for RNA? Use POWR Ratings for clearer insight into price direction.